Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | lysine (K)-specific methyltransferase 2A | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | relaxin/insulin-like family peptide receptor 1 | Starlite/ChEMBL | No references |
Homo sapiens | polo-like kinase 1 | Starlite/ChEMBL | No references |
Bacillus subtilis | 4'-phosphopantetheinyl transferase ffp | Starlite/ChEMBL | No references |
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Candida albicans | aminoadipate-semialdehyde dehydrogenase small subunit | 4'-phosphopantetheinyl transferase ffp | 224 aa | 183 aa | 27.3 % |
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Onchocerca volvulus | 4'-phosphopantetheinyl transferase ffp | 224 aa | 186 aa | 26.3 % | |
Entamoeba histolytica | hypothetical protein | 4'-phosphopantetheinyl transferase ffp | 224 aa | 198 aa | 28.3 % |
Candida albicans | aminoadipate-semialdehyde dehydrogenase small subunit | 4'-phosphopantetheinyl transferase ffp | 224 aa | 183 aa | 27.3 % |
Trichomonas vaginalis | conserved hypothetical protein | 4'-phosphopantetheinyl transferase ffp | 224 aa | 197 aa | 22.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | histone methyltransferase | 0.0011 | 0.0642 | 0.0459 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.4672 | 0.4568 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0028 | 0.2227 | 0.2227 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0004 | 0.0052 | 0.0052 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0382 | 0.0382 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0382 | 0.0382 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 1 | 1 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0114 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0382 | 0.0382 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0382 | 0.0382 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0382 | 0.0382 |
Echinococcus granulosus | L aminoadipate semialdehyde | 0.01 | 0.8762 | 0.8738 |
Schistosoma mansoni | cpg binding protein | 0.0037 | 0.299 | 0.2961 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0114 | 1 | 1 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0114 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0028 | 0.2227 | 0.2196 |
Brugia malayi | F/Y-rich N-terminus family protein | 0.0011 | 0.0629 | 0.0446 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0382 | 0.0382 |
Echinococcus granulosus | mixed lineage leukemia protein mll | 0.0009 | 0.045 | 0.0264 |
Trichomonas vaginalis | helicase, putative | 0.0008 | 0.0382 | 0.0382 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0056 | 0.4784 | 0.4784 |
Onchocerca volvulus | 0.0035 | 0.2811 | 0.267 | |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.4672 | 0.4651 |
Echinococcus multilocularis | cpg binding protein | 0.0037 | 0.299 | 0.2853 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 1 | 1 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0114 | 1 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.4672 | 0.4568 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0382 | 0.0382 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0066 | 0.562 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.01 | 0.8762 | 0.8738 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 1 | 1 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0005 | 0.0121 | 0.008 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.4672 | 0.4568 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0382 | 0.0382 |
Echinococcus multilocularis | mixed lineage leukemia protein mll | 0.0009 | 0.045 | 0.0264 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0004 | 0.0052 | 0.0052 |
Mycobacterium ulcerans | phosphopantetheinyl transferase, PptII | 0.0028 | 0.2227 | 0.5 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0114 | 1 | 1 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0642 | 0.0459 |
Giardia lamblia | Kinase, PLK | 0.0114 | 1 | 0.5 |
Trypanosoma brucei | polo-like protein kinase | 0.0114 | 1 | 1 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0382 | 0.0382 |
Schistosoma mansoni | low-density lipoprotein receptor (ldl) | 0.0006 | 0.0192 | 0.0152 |
Schistosoma mansoni | low-density lipoprotein receptor (ldl) | 0.0006 | 0.0192 | 0.0152 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 1 | 1 |
Mycobacterium ulcerans | 4'-phosphopantetheinyl transferase | 0.0028 | 0.2227 | 0.5 |
Plasmodium falciparum | holo-[acyl-carrier-protein] synthase, putative | 0.0028 | 0.2227 | 1 |
Treponema pallidum | 4'-phosphopantetheinyl transferase | 0.0028 | 0.2227 | 0.5 |
Schistosoma mansoni | aminoadipate-semialdehyde dehydrogenase | 0.01 | 0.8762 | 0.8757 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0074 | 0.6332 | 0.6317 |
Wolbachia endosymbiont of Brugia malayi | 4'-phosphopantetheinyl transferase | 0.0028 | 0.2227 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 1 | 1 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0008 | 0.0382 | 0.0382 |
Echinococcus multilocularis | L aminoadipate semialdehyde | 0.01 | 0.8762 | 0.8738 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0114 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0056 | 0.4784 | 0.4784 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0114 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0006 | 0.0192 | 0.0152 |
Mycobacterium leprae | conserved hypothetical protein | 0.0028 | 0.2227 | 0.5 |
Onchocerca volvulus | 0.01 | 0.8762 | 0.8738 | |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.4672 | 0.4651 |
Mycobacterium tuberculosis | holo-[acyl-carrier protein] synthase AcpS (holo-ACP synthase) (CoA:APO-[ACP]pantetheinephosphotransferase) (CoA:APO-[acyl-carrie | 0.0028 | 0.2227 | 0.5 |
Chlamydia trachomatis | holo [acyl-carrier protein] synthase | 0.0028 | 0.2227 | 0.5 |
Schistosoma mansoni | cpg binding protein | 0.0037 | 0.299 | 0.2961 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0008 | 0.0382 | 0.0382 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.4672 | 0.4568 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0009 | 0.045 | 0.0411 |
Schistosoma mansoni | hypothetical protein | 0.0006 | 0.0192 | 0.0152 |
Echinococcus granulosus | cpg binding protein | 0.0037 | 0.299 | 0.2853 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.4672 | 0.4568 |
Brugia malayi | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | 0.01 | 0.8762 | 0.8738 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0382 | 0.0382 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0009 | 0.045 | 0.0264 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0382 | 0.0382 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0642 | 0.0459 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 1 | 1 |
Trichomonas vaginalis | hypothetical protein | 0.0004 | 0.0052 | 0.0052 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.4672 | 0.4568 |
Plasmodium vivax | holo-[acyl-carrier-protein] synthase, putative | 0.0028 | 0.2227 | 0.5 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0035 | 0.2811 | 0.267 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0114 | 1 | 1 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0114 | 1 | 1 |
Schistosoma mansoni | low-density lipoprotein receptor (ldl) | 0.0006 | 0.0192 | 0.0152 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.4672 | 0.4651 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0382 | 0.0382 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0382 | 0.0382 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0006 | 0.0192 | 0.0152 |
Schistosoma mansoni | cpg binding protein | 0.0035 | 0.2811 | 0.2781 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0382 | 0.0382 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0382 | 0.0382 |
Schistosoma mansoni | kinase | 0.0058 | 0.492 | 0.4899 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0009 | 0.045 | 0.0264 |
Brugia malayi | CXXC zinc finger family protein | 0.0035 | 0.2811 | 0.267 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | > 99 uM | PUBCHEM_BIOASSAY: Dose response confirmation uHTS hits for MazEF TA System activators via a fluorescence-based single-stranded RNase assay counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504720, AID504743] | ChEMBL. | No reference |
EC50 (functional) | > 99 uM | PUBCHEM_BIOASSAY: Dose response confirmation uHTS hits for MazEF TA System activators via a fluorescence-based single-stranded RNase assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504720, AID504743] | ChEMBL. | No reference |
Potency (functional) | 1 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 1.122 um | PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)] | ChEMBL. | No reference |
Potency (functional) | = 2.8184 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 5.0119 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 5.9728 uM | PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Relaxin Receptor RXFP1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 16.5113 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (binding) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (binding) | 28.1838 uM | PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Vif-A3F Interactions: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 37.933 uM | PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488768, AID492961] | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540273] | ChEMBL. | No reference |
Potency (functional) | = 50.1187 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] | ChEMBL. | No reference |
Potency (functional) | 70.7946 uM | PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PubChem BioAssay. qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 100 uM | PubChem BioAssay. qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.